Hudson Capital Management LLC boosted its holdings in Humana Inc (NYSE:HUM) by 14.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,088 shares of the insurance provider’s stock after acquiring an additional 391 shares during the period. Hudson Capital Management LLC’s holdings in Humana were worth $1,045,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. FMR LLC raised its stake in Humana by 12.7% in the 2nd quarter. FMR LLC now owns 12,212,514 shares of the insurance provider’s stock valued at $3,634,811,000 after acquiring an additional 1,374,030 shares during the period. Northern Trust Corp raised its stake in Humana by 1.2% in the 2nd quarter. Northern Trust Corp now owns 1,687,211 shares of the insurance provider’s stock valued at $502,164,000 after acquiring an additional 20,480 shares during the period. Acadian Asset Management LLC raised its stake in Humana by 7.6% in the 2nd quarter. Acadian Asset Management LLC now owns 1,324,681 shares of the insurance provider’s stock valued at $394,262,000 after acquiring an additional 93,021 shares during the period. Massachusetts Financial Services Co. MA increased its position in Humana by 3.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 768,245 shares of the insurance provider’s stock worth $228,653,000 after buying an additional 26,303 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its position in Humana by 1.1% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 582,738 shares of the insurance provider’s stock worth $173,441,000 after buying an additional 6,522 shares during the period. Institutional investors and hedge funds own 92.99% of the company’s stock.

Several research analysts have weighed in on the company. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Friday, October 5th. SunTrust Banks increased their price objective on Humana to $380.00 and gave the stock a “hold” rating in a research report on Wednesday, September 19th. Cowen assumed coverage on Humana in a research report on Monday, September 17th. They set a “market perform” rating and a $372.00 price objective on the stock. Barclays assumed coverage on Humana in a research report on Thursday, September 13th. They set an “overweight” rating and a $370.00 price objective on the stock. Finally, Credit Suisse Group increased their price objective on Humana from $350.00 to $370.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Seven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $339.79.

In other news, CEO Bruce D. Broussard sold 18,000 shares of the stock in a transaction on Monday, September 10th. The stock was sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the sale, the chief executive officer now directly owns 71,085 shares of the company’s stock, valued at approximately $23,362,796.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Cynthia H. Zipperle sold 4,886 shares of the stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $321.89, for a total value of $1,572,754.54. The disclosure for this sale can be found here. Over the last three months, insiders have sold 40,284 shares of company stock worth $13,147,715. 0.60% of the stock is currently owned by insiders.

HUM opened at $328.80 on Thursday. The firm has a market cap of $46.64 billion, a PE ratio of 28.08, a P/E/G ratio of 1.69 and a beta of 0.97. Humana Inc has a 52-week low of $231.90 and a 52-week high of $341.30. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.47.

Humana (NYSE:HUM) last released its earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.79 by $0.17. The company had revenue of $14.26 billion for the quarter, compared to analyst estimates of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same period in the prior year, the firm posted $3.49 EPS. Equities analysts forecast that Humana Inc will post 14.18 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Thursday, September 27th. Humana’s dividend payout ratio (DPR) is currently 17.08%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Further Reading: How to Calculate Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.